ERBB3 is required for tumor promotion in a mouse model of skin carcinogenesis

Examination of HER3 targeting in cancer using monoclonal antibodies

(2015) Nadège Gaborit et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The promise of anti-ErbB3 monoclonals as new cancer therapeutics

(2015) Luigi Aurisicchio et al.   Oncotarget

Targeting of erbB3 receptor to overcome resistance in cancer treatment

(2014) Jian Ma et al.   Molecular Cancer

ErbB3 downregulation enhances luminal breast tumor response to antiestrogens

(2013) Meghan M. Morrison et al.   JOURNAL OF CLINICAL INVESTIGATION

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies

(2013) Luigi Fattore et al.   Journal of Translational Medicine

Negative Feedback Mechanisms Surpass the Effect of Intrinsic EGFR Activation during Skin Chemical Carcinogenesis

(2012) Maik Dahlhoff et al.   AMERICAN JOURNAL OF PATHOLOGY

A systematic review of worldwide incidence of nonmelanoma skin cancer

(2012) A. Lomas et al.   BRITISH JOURNAL OF DERMATOLOGY

Monoclonal antibody-induced ErbB3 receptor internalization and degradation inhibits growth and migration of human melanoma cells

(2012) Francesca Belleudi et al.   CELL CYCLE

Basal cell carcinoma — molecular biology and potential new therapies

(2012) Maria Kasper et al.   JOURNAL OF CLINICAL INVESTIGATION

Re-epithelialization from human skin explant cultures is promoted by ligand-activated HER3 receptor

(2010) Sofi Forsberg et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation

(2010) Fumin Shi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of HER3, the unpretentious member of the HER family, in cancer biology and cancer therapeutics

(2010) Dhara N. Amin et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Tumor-specific apoptosis caused by deletion of the ERBB3 pseudo-kinase in mouse intestinal epithelium

(2009) Daekee Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications

(2009) Erika L Abel et al.   Nature Protocols

NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation

(2009) Kristina Buac et al.   Pigment Cell & Melanoma Research

Beyond Wavy Hairs

(2008) Marlon R. Schneider et al.   AMERICAN JOURNAL OF PATHOLOGY

HER3 Is a Determinant for Poor Prognosis in Melanoma

(2008) M. Reschke et al.   CLINICAL CANCER RESEARCH